Skip to Content

Rotashield

Active Substance: rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant
Common Name: rotavirus vaccine, attenuated
ATC Code: J07BH
Marketing Authorisation Holder: Wyeth Lederle Vaccines S.A.
Active Substance: rotavirus serotype 1 reassortant, rotavirus serotype 2 reassortant, rotavirus serotype 3 rhesus, rotavirus serotype 4 reassortant
Status: Withdrawn
Authorisation Date: 1999-05-07
Therapeutic Area: Rotavirus Infections Immunization
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

RotaShield is indicated for active immunisation of infants aged 6 weeks to 30 weeks for prevention of severe clinical manifestations of gastro-enteritis caused by rotavirus serotypes 1, 2, 3 and 4 of group A.

The marketing authorisation for Rotashield has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide